The US Food and Drug Administration (FDA) has approved Eli Lilly’s Inluriyo (imlunestrant) to treat advanced or metastatic ...
Pharming Group has announced that the US Food and Drug Administration (FDA) has accepted its supplemental New Drug ...
Micheal Tague, President of Porterhouse Medical US, commented: “We are thrilled to welcome Jennifer to the team. Her ...
What constitutes a positive outcome for patients does not always align with the outcomes of interest to researchers’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback